Please login to the form below

Not currently logged in
Email:
Password:

Germany

This page shows the latest Germany news and features for those working in and with pharma, biotech and healthcare.

AstraZeneca divests Seroquel rights to focus on key therapy areas

AstraZeneca divests Seroquel rights to focus on key therapy areas

Second divestment to Germany-based Cheplapharm this year. AstraZeneca has sold the commercial rights to schizophrenia and bipolar disorder drugs Seroquel and Seroquel XR to Cheplapharm. .

Latest news

More from news
Approximately 44 fully matching, plus 837 partially matching documents found.

Latest Intelligence

  • Building European biotech firms to rival those of the US Building European biotech firms to rival those of the US

    Germany is European biotech’s sleeping giant. “Germany is Europe’s great untapped player in biotech,” said Richard. ... For a number of reasons, such as taxes and red tape, the sector hasn’t really taken off there as much as it could have until

  • European biotech: a new generation of leaders emerges European biotech: a new generation of leaders emerges

    potential academic researchers across the continent, with a number of specialist venture capital firms and incubators helping to build success stories in the UK, France, Germany, Belgium and Denmark across a ... Morphosys. One of Europe’s star

  • A new EU in the making, what lies ahead for pharma? A new EU in the making, what lies ahead for pharma?

    The HTA file is in a difficult situation at the moment with Germany and France blocking it. ... For smaller companies however, the stakes are higher. If France, Germany and a few other countries want to support innovation and faster market uptake up to

  • Is anybody listening? Is anybody listening?

    Similarly, authorities in Germany, China, Russia and Australia – as well as the EU in general – are all taking measures to clamp down on companies that aren’t doing enough to fulfil

  • Bluebird: on a mission to ‘recode’ the DNA of healthcare Bluebird: on a mission to ‘recode’ the DNA of healthcare

    Bluebird is focusing on Germany, Italy, France and the UK as its initial launch markets, as 90% of Europe’s beta thalassemia patients live in these four countries. ... He said conversations with Germany’s sick funds have been constructive so far, not

More from intelligence
Approximately 9 fully matching, plus 123 partially matching documents found.

Latest appointments

More from appointments
Approximately 2 fully matching, plus 74 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 71 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OUTiCO

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

Language barriers: Obesity has become a loaded word
...
Spotlight interview: 15 minutes on digital in medical communications
Gemma Allen, Head of Digital Communications, OPEN Health takes 15 minutes to answer some key questions on digital in medical communications...
Generating data on long-term outcomes with gene and other advanced therapies
Gene therapy and advanced cell-based therapies offer patients hope and the potential to make them ‘chronically well’....

Infographics